delta-Atracotoxins from australian funnel-web spiders compete with scorpion alpha-toxin binding but differentially modulate alkaloid toxin activation of voltage-gated sodium channels. 1998

M J Little, and C Zappia, and N Gilles, and M Connor, and M I Tyler, and M F Martin-Eauclaire, and D Gordon, and G M Nicholson
Department of Health Sciences, University of Technology, Sydney, Broadway, New South Wales 2007, Australia.

delta-Atracotoxins from the venom of Australian funnel-web spiders are a unique group of peptide toxins that slow sodium current inactivation in a manner similar to scorpion alpha-toxins. To analyze their interaction with known sodium channel neurotoxin receptor sites, we studied their effect on [3H]batrachotoxin and 125I-Lqh II (where Lqh is alpha-toxin II from the venom of the scorpion Leiurus quinquestriatus hebraeus) binding and on alkaloid toxin-stimulated 22Na+ uptake in rat brain synaptosomes. delta-Atracotoxins significantly increased [3H]batrachotoxin binding yet decreased maximal batrachotoxin-activated 22Na+ uptake by 70-80%, the latter in marked contrast to the effect of scorpion alpha-toxins. Unlike the inhibition of batrachotoxin-activated 22Na+ uptake, delta-atracotoxins increased veratridine-stimulated 22Na+ uptake by converting veratridine from a partial to a full agonist, analogous to scorpion alpha-toxins. Hence, delta-atracotoxins are able to differentiate between the open state of the sodium channel stabilized by batrachotoxin and veratridine and suggest a distinct sub-conductance state stabilized by delta-atracotoxins. Despite these actions, low concentrations of delta-atracotoxins completely inhibited the binding of the scorpion alpha-toxin, 125I-Lqh II, indicating that they bind to similar, or partially overlapping, receptor sites. The apparent uncoupling between the increase in binding but inhibition of the effect of batrachotoxin induced by delta-atracotoxins suggests that the binding and action of certain alkaloid toxins may represent at least two distinguishable steps. These results further contribute to the understanding of the complex dynamic interactions between neurotoxin receptor site areas related to sodium channel gating.

UI MeSH Term Description Entries
D008297 Male Males
D009498 Neurotoxins Toxic substances from microorganisms, plants or animals that interfere with the functions of the nervous system. Most venoms contain neurotoxic substances. Myotoxins are included in this concept. Alpha-Neurotoxin,Excitatory Neurotoxin,Excitotoxins,Myotoxin,Myotoxins,Neurotoxin,Alpha-Neurotoxins,Excitatory Neurotoxins,Excitotoxin,Alpha Neurotoxin,Alpha Neurotoxins,Neurotoxin, Excitatory,Neurotoxins, Excitatory
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001496 Batrachotoxins Batrachotoxin is the 20-alpha-bromobenzoate of batrachotoxin A; they are toxins from the venom of a small Colombian frog, Phyllobates aurotaenia, cause release of acetylcholine, destruction of synaptic vesicles and depolarization of nerve and muscle fibers. Batrachotoxin B
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D001667 Binding, Competitive The interaction of two or more substrates or ligands with the same binding site. The displacement of one by the other is used in quantitative and selective affinity measurements. Competitive Binding
D001692 Biological Transport The movement of materials (including biochemical substances and drugs) through a biological system at the cellular level. The transport can be across cell membranes and epithelial layers. It also can occur within intracellular compartments and extracellular compartments. Transport, Biological,Biologic Transport,Transport, Biologic

Related Publications

M J Little, and C Zappia, and N Gilles, and M Connor, and M I Tyler, and M F Martin-Eauclaire, and D Gordon, and G M Nicholson
March 1998, Journal of neurochemistry,
M J Little, and C Zappia, and N Gilles, and M Connor, and M I Tyler, and M F Martin-Eauclaire, and D Gordon, and G M Nicholson
September 2012, Toxicon : official journal of the International Society on Toxinology,
M J Little, and C Zappia, and N Gilles, and M Connor, and M I Tyler, and M F Martin-Eauclaire, and D Gordon, and G M Nicholson
November 1989, Molecular pharmacology,
M J Little, and C Zappia, and N Gilles, and M Connor, and M I Tyler, and M F Martin-Eauclaire, and D Gordon, and G M Nicholson
August 1997, The Journal of membrane biology,
M J Little, and C Zappia, and N Gilles, and M Connor, and M I Tyler, and M F Martin-Eauclaire, and D Gordon, and G M Nicholson
October 2022, International journal of molecular sciences,
M J Little, and C Zappia, and N Gilles, and M Connor, and M I Tyler, and M F Martin-Eauclaire, and D Gordon, and G M Nicholson
February 2001, The Journal of experimental biology,
M J Little, and C Zappia, and N Gilles, and M Connor, and M I Tyler, and M F Martin-Eauclaire, and D Gordon, and G M Nicholson
January 2018, Current pharmaceutical biotechnology,
M J Little, and C Zappia, and N Gilles, and M Connor, and M I Tyler, and M F Martin-Eauclaire, and D Gordon, and G M Nicholson
May 1985, Brain research,
M J Little, and C Zappia, and N Gilles, and M Connor, and M I Tyler, and M F Martin-Eauclaire, and D Gordon, and G M Nicholson
April 2004, Toxicon : official journal of the International Society on Toxinology,
M J Little, and C Zappia, and N Gilles, and M Connor, and M I Tyler, and M F Martin-Eauclaire, and D Gordon, and G M Nicholson
January 2012, PloS one,
Copied contents to your clipboard!